Bavarian Nordic to Host Full Year 2010 Conference Call
KVISTGÃ…RD, Denmark - March 8, 2011 - Bavarian Nordic A/S (NASDAQ OMX:Â BAVA)
announces its 2010 full year results on Thursday, March 10.
The company will host two conference calls on the same day at 9 a.m. (CET) and
again at 4 p.m. (CET). A short presentation will be held by President and CEO,
Anders Hedegaard, followed by a Q&A session.
Also attending are Reiner Laus, EVP & Division President Cancer Vaccines, Ole
Larsen, EVP & CFO and Rolf Sass SÃ¸rensen, VP Investor Relations &
Dial-in numbers for the conference call are:Â Denmark: +45 32 71 46 07, UK: +44
(0)20 7162 0077, US: +1 334 323 6201. For additional countries and further
details please visit http://www.bavarian-nordic.com/ar2010 where also the
accompanying presentation will be available in advance of the conference call.
Rolf Sass SÃ¸rensen, Vice President Investor Relations & Communications.
Phone: +45 33 26 83 83
About Bavarian Nordic
Bavarian Nordic is a leading industrial biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's clinical pipeline
targets cancer and infectious diseases, and includes seven development
programmes. Two programmes under preparation for Phase 3: PROSTVACÂ®, a
therapeutic vaccine for advanced prostate cancer is being developed under a
collaboration agreement with the National Cancer Institute, and IMVAMUNEÂ®, a
third-generation smallpox vaccine is being developed under a contract with the
Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.
For more information please visit www.bavarian-nordic.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via Thomson Reuters ONE